Year of Award
2024
Document Type
Professional Paper
Degree Type
Master of Science (MS)
Degree Name
Pharmaceutical Sciences and Drug Design
Department or School/College
Pharmaceutical Science and Drug Design
Committee Chair
Dr. Erica Woodahl
Commitee Members
Erica L. Woodahl, Hayley Blackburn, Katie Holick, James Caringi, Katrina Claw
Keywords
pharmacogenomics, pharmacogenetics, tobacco cessation, qualitative research, underserved communities
Subject Categories
Medical Genetics | Other Pharmacy and Pharmaceutical Sciences
Abstract
Pharmacogenomics research has predominantly focused on populations of European ancestry, limiting the application for diverse populations such as American Indian and Alaska Native (AIAN) communities. Our community-centric study aims to understand perspectives of utilizing pharmacogenomics to guide tobacco cessation in an AIAN community using a survey with qualitative and quantitative components. We assessed participant (n=273) tobacco usage and cessation history, pharmacogenomics knowledge, and perceptions of utilizing pharmacogenomics in the context of tobacco cessation. We found that the majority of participants (92%) were aware of risks associated with tobacco usage and believe it to be a problem within their community (76%). Our results showed that 29% of participants had some level of knowledge regarding pharmacogenomics and only 6% had previously participated in pharmacogenetics research, demonstrating the need for further education and awareness. Community involvement was a priority for participants, with 64% preferring Tribal inclusion in all research stages and 63% favoring partnerships with local health centers. We also found support for future research, with 68% viewing pharmacogenomics as a beneficial tool. Concerns were raised regarding handling of genetic material and result dissemination emphasizing the importance of ethical research practices, transparent communication, and community partnership. Our findings serve as a foundation for shaping future research efforts and developing a framework for implementing tobacco cessation interventions. Our community-centered approach addresses the specific needs of this AIAN community and offers insights applicable to research practices within other underserved and marginalized populations, particularly those with a historical distrust towards research.
Recommended Citation
Davies, Madeline Lousie, "PERSPECTIVES OF UTILIZING PHARMACOGENOMICS TO INFORM TOBACCO CESSATION: SURVEY RESULTS FROM AN AMERICAN INDIAN COMMUNITY" (2024). Graduate Student Theses, Dissertations, & Professional Papers. 12351.
https://scholarworks.umt.edu/etd/12351
© Copyright 2024 Madeline Lousie Davies